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Highlights: Influence of the intestinal microbiota on disease susceptibility in kittens with 
experimentally-induced carriage of atypical enteropathogenic Escherichia coli.  
 
 Atypical EPEC, derived from kittens with diarrhea, promotes significant changes in 
intestinal function of healthy kittens following experimental carriage. 
 Disruption of the resident intestinal microbiota prior to aEPEC infection increases 
susceptibility of healthy kittens to intestinal water loss and associated decreases in 
fecal consistency. 
 Enrichment of the intestinal microbiota with a commensal bacteria, Enterococcus 
hirae, promotes enhanced barrier function of kittens following experimental aEPEC 
carriage. 
 
ABSTRACT 
Typical enteropathogenic E. coli (tEPEC) carries the highest hazard of death in children with 
diarrhea and atypical EPEC (aEPEC) was recently identified as significantly associated with 
diarrheal mortality in kittens. In both children and kittens there is a significant association between 
aEPEC burden and diarrheal disease, however the infection can be found in individuals with and 
without diarrhea. It remains unclear to what extent, under what conditions, or by what mechanisms 
aEPEC serves as a primary pathogen in individuals with diarrhea. It seems likely that a 
combination of host and bacterial factors enable aEPEC to cause disease in some individuals and 
not in others. The purpose of this study was to determine the impact of aEPEC on intestinal 
function and diarrhea in kittens following experimentally-induced carriage and the influence of a 
disrupted intestinal microbiota on disease susceptibility. Results of this study identify aEPEC as a 
potential pathogen in kittens. In the absence of disruption to the intestinal microbiota, kittens are 
resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal 
absorption and permeability. Antibiotic-induced disruption of the intestinal microbiota prior to 
infection increases subsequent intestinal water loss as determined by % fecal wet weight. 
Enrichment of the intestinal microbiota with a commensal member of the feline mucosa-associated 
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microbiota, Enterococcus hirae, ameliorated the effects of aEPEC experimental infection on 
intestinal function and water loss. These observations begin to unravel the mechanisms by which 
aEPEC infection may be able to exploit susceptible hosts. 
 
 
 
 
1. Introduction  
Diarrhea is responsible for the death of an estimated 500,000 children per year worldwide 
with the greatest mortality occurring in developing countries (Kirk et al., 2015; Kotloff et al., 2013; 
Liu et al., 2016). Diarrhea in most of these children is caused by a mere handful of infectious 
agents (Kirk et al., 2015; Kotloff et al., 2013). In particular, enteropathogenic E. coli (EPEC) is 
responsible for over 81 million cases of diarrhea per year of which 17 million cases are diagnosed 
in children (Kirk et al., 2015). Typical enteropathogenic Escherichia coli (tEPEC) is a common 
bacterial cause of diarrhea in children and, compared to other common enteropathogens, is 
associated with the highest hazard of death (Kotloff et al., 2013). While tEPEC is largely 
undisputed as a cause of diarrhea, the pathogenicity of atypical EPEC (aEPEC), which lack the 
plasmid responsible for expression of bundle forming pili, is confounded by frequent observation 
in children with and without signs of diarrhea (Barletta et al., 2011; Enserink et al., 2014; Estrada-
Garcia et al., 2009). A rising incidence of aEPEC infection in both developing and developed 
countries has renewed controversy over the pathogenicity of aEPEC in children (Hu and Torres, 
2015). 
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Similar to children in developing countries, there exists a high mortality rate associated 
with diarrheal disease in young kittens residing in animal shelters across the United States and 
elsewhere (Ghosh et al., 2013; Murray et al., 2008). We recently identified that shelter kittens have 
a high prevalence of aEPEC carriage (Ghosh et al., 2013; Watson et al., 2017). The kitten carriage 
mirrors observations of aEPEC carriage in children by being observed in both sick and healthy 
individuals but with a significantly higher bacterial burden in individuals with diarrhea as 
compared to those with asymptomatic infection (Barletta et al., 2011; Watson et al., 2017). For 
both children and kittens it remains unclear as to what extent, and under what conditions, or by 
what mechanisms aEPEC serves as a primary cause of diarrhea. It seems likely that some 
combination of bacterial and host factors enable aEPEC to access the intestinal epithelium and 
thereupon promote pathogenicity in some hosts and not others. Directly pathogenic effects of 
EPEC are believed to commence when these bacteria attach to and efface the microvilli of 
intestinal epithelial cells and inject effector proteins into the epithelial cells resulting in disrupted 
regulation of paracellular permeability and ion transport mechanisms (Glotfelty et al., 2014; Hu 
and Torres, 2015; McNamara et al., 2001; Thanabalasuriar et al., 2010). While the cellular 
mechanisms have been well characterized in vitro, the pathogenesis of the infection in vivo is less 
well understood. Kittens with diarrhea-related death which test positive for aEPEC have more 
severe inflammation and epithelial injury within the small intestine and more often require 
parenteral fluid therapy compared to kittens with diarrhea-related death and negative test results 
for aEPEC (Watson et al., 2017).  
We have previously demonstrated, in an autopsy study of kitten mortality, that aEPEC 
colonize the intestinal epithelium and this is associated with changes in the predominant species 
of the mucosa-associated enterococci (Ghosh et al., 2013). Specifically, prevalence of a major 
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commensal species, Enterococcus hirae, was replaced by Enterococcus faecalis. Experimental 
animal models of EPEC infection similarly suggest a strong influence of the microbiome and 
specific members of the microbiome on disease outcome (Vong et al., 2015; Walsham et al., 2016; 
Wlodarska et al., 2011). Accordingly, the purpose of this study was to determine if aEPEC is 
sufficient to cause diarrhea or intestinal dysfunction in kittens with experimentally-induced 
infection and the influence of a disrupted intestinal microbiota on disease susceptibility. We 
additionally examined the effect of a probiotic formulation of feline Enterococcus hirae on the 
observed manifestations of aEPEC-induced disease. Our rationale was that identification of 
aEPEC as a primary cause of intestinal disease in kittens could provide a unique opportunity for 
development of life-saving treatment strategies for both kittens and possibly children with aEPEC 
infection. In particular, demonstration of a positive impact of commensal bacteria in treatment or 
prevention of aEPEC-associated disease would be of immediate benefit to improving the burden 
of diarrhea in infected kittens. 
 
2. Materials and methods 
2.1. Kitten acquisition and screening 
Six-week-old kittens of either sex were obtained from a commercial vendor. A fecal sample 
was obtained from each kitten and sent to a commercial laboratory (IDEXX Laboratories Inc, 
Westbrook, Maine) for diagnostic qPCR testing to detect feline coronavirus, Tritrichomonas 
foetus, Cryptosporidium spp, feline panleukopenia virus, Clostridium perfringens alpha toxin and 
enterotoxin, Giardia spp, Salmonella spp, Toxoplasma gondii, Campylobacter jejuni, and 
Campylobacteri coli.  
A
CE
PT
ED
 M
AN
US
CR
IPT
 6 
Individual kittens were housed in separate cages and fed a commercially available dry food 
formulated for cats (Hill’s® Science Diet kitten healthy development; Topeka, Kansas) ad libitum 
throughout the study. Each kitten also received ¼ teaspoon of canned cat food (Hill’s® Science 
Diet a/d) each morning. Water, which cultured negative for E. coli prior to kittens’ arrival, was 
provided ad libitum. Kittens were housed under conditions of controlled light cycle and ambient 
temperature and were handled in compliance with biosafety level 2 guidelines. Kittens were 
acclimated to this new environment for 5 days. Kittens were cared for in accordance with the Guide 
for the Care and Use of Laboratory Animals in AAALAC-accredited facilities at the North 
Carolina State University. The study was approved by the North Carolina State 
University Institutional Animal Care and Use Committee. No animals were euthanized for the 
purpose of the study. 
 
2.2. Influence of antibiotic treatment 
To determine the impact of an altered gut microbiota on susceptibility to aEPEC-associated 
intestinal disease, two separate groups of kittens were studied a shown in Figure 1. Group A 
included eight kittens that did not receive antibiotics prior to experimental infection with aEPEC. 
After completion of the study in Group A kittens, a second group (Group B) of eight kittens were 
administered oral antibiotics prior to experimental infection with aEPEC. The antibiotics 
administered were amoxicillin/clavulanate (12.5 mg/kg twice daily) (Zoetis, Parsippany, New 
Jersey) and pradofloxacin (7.5 mg/kg once daily) (Bayer, Shawnee Mission, Kansas) given orally 
for 5 consecutive days followed by a washout period of 2 days prior to experimental infection. 
These antibiotics were selected to broadly disrupt the native gut microbiota by providing 
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broad-spectrum activity against aerobic and anaerobic Gram-positive and Gram-negative 
bacteria. 
 
2.3. Experimental aEPEC infection 
As this study was an exploratory study on a bacterium of unknown pathogenicity in cats, 
we included 3 serologically and genetically distinct isolates of feline aEPEC in our experimental 
infection. Our rationale for selecting these 3 aEPEC was that they were each isolated from a kitten 
that died with diarrhea (Watson et al., 2017), selecting 3 should increase the likelihood of infection, 
and exposure to multiple isolates reflects a more natural setting of infection. Each isolate was 
confirmed to be E. coli by means of matrix assisted laser desorption ionization-time of flight mass 
spectrometry (MALDI-TOF) (VITEK MS; Biomérieux, Marcy l’Etoile, France)  and identified 
as aEPEC by demonstrating the presence of eae and absence of genes encoding bundle-forming 
pilus and Shiga-toxins 1 and 2 (DebRoy and Maddox, 2001). Isolates were stored in 50% lysogeny 
broth (LB)-glycerol at -80°C. Prior to use in experimental infection, each isolate was grown 
separately overnight on LB agar at 37°C. A single colony from each plate was individually 
suspended in LB broth and grown overnight. The following morning, an overnight culture of each 
isolate was individually sub-cultured at 1:25 concentration in LB and incubated on a shaker 
platform at 37°C until an OD600 of 0.4 was obtained (~ 10
8 CFU/ml). To prepare the inoculum for 
each kitten, a one-milliliter aliquot of each isolate (3 ml total) was combined in a conical tube and 
centrifuged at 2000 × g for 15 minutes. The supernatant was removed and the pellet was 
reconstituted with 100 µl of sterile water. The 100 μl aliquot of aEPEC was then added to ¼ 
teaspoon of canned cat food which was offered to each kitten and promptly ingested. A tandem 
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mixture of the isolates was simultaneously prepared for serial dilutions and plate counting to 
confirm the CFU/ml of the inoculum used for infection.  
 
2.4. Characterization of aEPEC isolates used for experimental infection 
Genomic DNA from each aEPEC isolate was examined by PCR for the presence of 
virulence-associated genes spanning the locus of enterocyte effacement (LEE). Included were 
genes that encode proteins of the T3SS, including an ATPase (escN) and a translocated protein 
(escV) and the LEE regulator (ler). Also selected for PCR was the non-LEE gene lymphocyte 
inhibitory factor (lifA) (otherwise known as enterohemorrhagic E. coli (EHEC) factor for 
adherence (efa1)). All conventional PCR assays were performed using previously published 
primer sequences and reaction conditions (Hazen et al., 2013; Kyaw et al., 2003; Narimatsu et al., 
2010; Sharma and Zuerner, 2004). PCR products were separated by electrophoresis on 1.5% 
agarose gels stained with either ethidium bromide or commercially available DNA stain (GelRed, 
Biotium, Fremont, CA) and visualized using a UV imager (Bio-Rad, Hercules, CA or UVP LLC, 
Upland, CA). 
Antimicrobial susceptibility testing was performed by the Clinical Microbiology and 
Molecular Diagnostics Laboratory at North Carolina State University. The minimum inhibitory 
concentration of each E. coli isolate was determined by microbroth dilution using a commercial 
platform (COMPAN2F plates; Trek Sensitre, ThermoFisher Scientific) and manufacturer-
provided methodology. Clinical interpretations were made according to Clinical and Laboratory 
Standards Institute (CLSI) guidelines (CLSI VET01S).      
 
2.5. Establishing a dose for experimental aEPEC infection 
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An inoculum of 108 cfu for each aEPEC used in experimental infections was chosen based 
on estimated burden of aEPEC in kittens with diarrhea, survival of aEPEC under simulated gastric 
conditions, and previously published inoculum sizes. We used qPCR data obtained from 
amplification of eae from the fecal DNA of naturally infected kittens and its application to a 
previously developed standard curve for the relationship between the cycle threshold (Ct) of eae 
and CFU of aEPEC (Watson et al., 2017) to estimate the burden of aEPEC carriage in kittens with 
diarrhea. To determine the influence of the gastric environment on survival of aEPEC, growth of 
the aEPEC isolates was quantified under conditions designed to simulate the volume, acidity, ion 
composition, and pepsin concentration of feline gastric contents (Chandler et al., 1997). Briefly, a 
mixture of all 3 aEPEC isolates was inoculated into each of two 50 ml conical tubes containing 5 
milliters of buffer. The buffer consisted of 2 solutions (0.2 M KCl and 0.2 M HCl) that were 
combined to achieve a target pH of 2 followed by the addition of 0.05 mg/ml pepsin. To replicate 
the vehicle intended for use in delivery of the experimental aEPEC inoculum, ¼ teaspoon of 
canned cat food (Hill’s® Science Diet a/d) was included in each tube. The solution was incubated 
in a shaking water bath (30 RPM) at 37C for 2 hours to simulate gastric temperature and emptying 
time (Chandler et al., 1997). Serial dilutions of the original inoculum and aliquots obtained after 
“infection” of the simulated gastric environments were plated and bacteria colonies counted to 
establish the CFU/ml of aEPEC prior to and after incubation in the gastric environment. Isolates 
obtained post-incubation were not identified by pulsotype or serotype.  
 
2.6. Clinical disease assessment 
Kittens were examined daily for clinical signs of illness including measurement of body 
weight, food consumption, and fecal consistency. Rectal temperature and heart rate were obtained 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 10 
every other day. Fecal consistency was scored using published criteria (Nestlé-Purina, St. Louis, 
Missouri) with scores ranging from 1 (very hard and dry) to 7 (watery with no texture). Fecal wet 
weight, a quantifiable measurement of fecal water content, was determined by obtaining an initial 
fecal weight followed by desiccation of feces at 60°C for 24 hours. Dried feces were weighed and 
the equation 
𝑊𝑖−𝑊𝑑
𝑊𝑖
𝑥 100 (𝑊𝑖 = initial fecal weight and 𝑊𝑑 = dried fecal weight) was used to 
calculate a % fecal wet weight.  
 
2.7 Culture and molecular quantification of fecal aEPEC shedding 
Each kitten had a fecal culture performed every other day for detection of aEPEC shedding. 
Fecal material was diluted in sterile PBS and plated on MacConkey agar. Eight morphologically 
representative E. coli colonies were subcultured onto LB agar plates and biochemical tests 
including indole, pyrrolidonyl arylamidase, and oxidase (Becton, Dickinson and Company, 
Franklin Lakes, NJ) were used to presumptively identify bacteria as E. coli. Each of the eight E. 
coli isolates was frozen in 50% LB-glycerol freezing media and stored at -80°C. The DNA was 
evaluated for eae using qPCR with previously published primers and reaction conditions (Franck 
et al., 1998). Three EPEC isolates obtained from each kitten on day 3 post-infection were further 
characterized using pulsed-field gel electrophoresis. Molecular detection of aEPEC, by means of 
qPCR amplification of eae from fecal DNA, was performed every other day prior to infection and 
daily for 7 days post-infection. DNA extractions were performed using a commercial kit (Zymo 
Research Corp. Irvine, CA) and stored at -80°C prior to use.  
 
2.8 Pulsed-field gel electrophoresis 
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Pulsed-field gel electrophoresis was performed according to the PulseNet protocol. Briefly, 
overnight cultures of aEPEC were equilibrated in cell suspension buffer solution to an absorbency 
of 1.08-1.1 at a wavelength of 610 nm and mixed with 1% Seakem gold agarose (Thermo Fisher 
Scientific, Waltham, MA) for plug formation. The plugs were sectioned to an equal size with a 
width of 2-mm and then individually digested with restriction enzyme XbaI (New England 
Biolabs, Ipswich, MA). Plugs were embedded into an agarose gel and restriction fragments were 
separated by electrophoresis at 6 volts/cm for 19 hours. Standardization across gels was 
accomplished by including Salmonella enterica serotype Braenderup H9812 digested with XbaI 
in each gel. Gels were stained with a commercially available DNA stain (GelRed, Biotium, 
Fremont, CA) following the manufacturer’s protocol and imaged with a UV imager (Bio-Rad, 
Hercules, CA). Gel images were subsequently inserted into and analyzed by BioNumerics software 
(Applied Maths, Inc., Austin, TX).  
 
2.9. Intestinal function and permeability testing 
Intestinal function testing was performed on each kitten on day 6 of acclimation and again 
on day 4 post-infection with aEPEC as shown in Figure 1. At each time, kittens were lightly 
anesthetized by mask inhalation of isofluorane gas and then orogastrically intubated for 
administration of a mixture of iohexol (Klenner et al., 2009) and D-xylose (Eberts et al., 1979). 
Doses used for iohexol and D-xylose were extrapolated from previously published studies 
(Klenner et al., 2009; Nix et al., 1993). The final mixture contained 2 ml of a 350 mg/ml solution 
of iohexol (Omnipaque, GE Healthcare, Princeton NJ), 0.5 g of D-xylose (Sigma-Aldrich Corp., 
St. Louis, MO), and sufficient sterile water to achieve a total solution volume of 11 ml. At 1.5 
hours post-gavage, kittens were again lightly anesthetized by mask inhalation of isofluorane gas 
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and a 1 ml whole blood sample was collected by jugular venipuncture. Blood samples were 
allowed to clot for 30 minutes and then centrifuged at 2000 × g for 20 minutes to separate the 
serum from the red blood cells. Serum was stored at -20°C prior to batch assay. 
 
2.10. D-xylose absorption and iohexol permeability assays 
Serum D-xylose concentrations were measured using a phloroglucinol assay as previously 
described (Eberts et al., 1979). The colorimetric reagent was composed of 0.25 g phloroglucinol 
(Sigma-Aldrich, Corp., St. Louis, MO), 50 ml of glacial acetic acid, and 5 ml HCl (Thermo Fisher 
Scientific, Waltham, MA). Twenty microliters of serum from each kitten was mixed with 2 ml of 
the color reagent and maintained at 100°C for 4 minutes and then absorbency at 554 nm was 
measured using a spectrophotometer (BioTek Synergy 2, Biotek US, Winooski, VT). Standard 
dilutions of D-xylose in feline serum (Immunoreagents, Raleigh, NC) ranging from 3.125 mg/dl 
to 100 mg/dl were used to create a standard curve for each reaction. The direct effect of aEPEC 
bacteria on D-xylose concentration was examined by co-culture of aEPEC (108 CFU each) in fresh 
LB containing D-xylose (5 mg/ml) at 37C for 2 hours in triplicate. D-xylose remaining after 
incubation with aEPEC was measured using the phloroglucinol assay. The effect of glucose on the 
D-xylose assay was determined by performing the assay on feline serum with standard dilutions 
of glucose. A commercially available ELISA (BioPhysics Assay Laboratory Inc. Worcester, MA) 
was used to determine serum iohexol concentrations following the manufacturer protocol (Frias et 
al., 2012; Klenner et al., 2009).  
 
2.11. Eradication of aEPEC from experimentally infected kittens 
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After a 1 week duration of post-infection observation, kittens were treated with oral 
pradofloxacin (7.5 mg/kg) (Bayer, Shawnee Mission, Kansas) once a day for 7 days to eliminate 
aEPEC carriage. At the end of the antibiotic treatment, absence of shedding of aEPEC was 
established by negative results of fecal culture for aEPEC. 
 
2.12 Impact of oral administration of commensal feline Enterococcus hirae 
For each experimental group of 8 kittens, individuals were randomly and equally divided 
into two separate rooms containing 4 kittens each. Kittens in one room received a probiotic while 
those in the other received placebo/vehicle. The investigators were blinded as to which room of 
kittens received the vehicle versus the probiotic. The administered probiotic was manufactured 
from a single, well-characterized isolate of feline Enterococcus hirae. The isolate (1002-2) was 
cultured from the mucosa-associated flora of the ileum from a healthy kitten in which histological 
evidence of E. hirae attachment to the intestinal epithelium was documented. The isolate lacked 
all virulence characteristics, the results of which were previously reported (Ghosh et al., 2013).  
The selected isolate of feline E. hirae was prepared for use as a probiotic by culturing in 
Biostat B-plus reactors fed with MB medium containing 20 g/L glucose using a variable speed 
pump (Bruno-Barcena et al., 1998). The dilution rate (D=0.17 h-1), temperature (37°C), and pH 
(5.5) were maintained. The bacteria were collected from the reactor overflow and concentrated in 
PBS at pH=7. Glucose consumption and accumulation of lactate and other fermentation products 
were monitored with high-performance liquid chromatography (Shimadzu Corporation, Kyoto, 
Japan) performed under isocratic conditions at 65°C, a mobile phase of 5 mM sulfuric acid 
(H2SO4) at a 0.4 ml/min flow rate using an Alltech IOA-1000 organic acids column (300 mm x 
7.8 mm, Alltech, IL, USA), and coupled to a refractive-index detector. Numbers of viable cells 
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were confirmed by plating on M17 agar and incubating at 37°C for 72 hours. For each sample, 
three plates were prepared from each dilution and recorded as the average of three independent 
counts. Finalized probiotic and vehicle (bacteriological peptone) were stored at -80˚C. 
Aliquots containing 10-15 mg of probiotic powder (2.85 – 4.28  108 CFU of E. hirae) or 
vehicle were prepared under sterile conditions on a single day and stored at -80°C until needed. 
One extra aliquot was prepared and plated to confirm CFU count. To confirm survival in a gastric 
environment, 2 additional aliquots were incubated in a simulated gastric environment as described 
for aEPEC. On each morning of administration, the aliquots were thawed, mixed with 100 l of 
sterile water, and inoculated into ¼ teaspoon of canned cat food. The timing of administration of 
E. hirae or vehicle in relation to other interventions in the study of each experimental group is 
shown in Figure 1. 
 
2.13. Confirmation of E. hirae colonization 
Fecal culture for isolation of enterococci was performed every other day over the duration 
of the study. Fecal material was mixed with sterile PBS and plated on m-Enterococcus (BD 
Difco™, Fisher Scientific, Waltham MA) plates. Five individual isolates of enterococci were sub-
cultured and each isolate was frozen in 50% LB-glycerol and stored at -80°C. DNA from each 
isolate was liberated from bacteria by heating at 100°C for 30 minutes. Enterococci were identified 
as E. hirae by means of PCR using primers targeting the transglycosylase gene sequence specific 
to the species (murG) (Arias et al., 2006). Quantitative PCR for murG was performed to determine 
the amount of E. hirae DNA present in fecal DNA from each kitten. Amplifications were 
performed with an initial denaturation at 95°C for 2 minutes, followed by 30 cycles of denaturation 
at 95°C for 15 seconds, annealing at 55°C for 2 minutes, and extension at 72°C for 3 minutes. 
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2.14. Statistical analyses 
Data were tested for normal distribution (Kolmogorov-Smirnov) and equal variance 
(Leven median test) and analyzed using parametric or nonparametric statistics as appropriate. 
Significant differences in proportion of observations between groups was analyzed using Chi-
square and Fisher exact tests. Differences in the mean or median values of continuous data between 
groups of kittens were analyzed using Student’s t-tests or Mann-Whitney rank sum test, 
respectively. Changes in absorption of D-xylose, permeability to iohexol, and % fecal wet weight 
between baseline and post-infection measurements were analyzed using Student’s paired t-test. 
Analyses were conducted using commercially available software (Sigmaplot 12, Systat Software, 
Inc., San Jose, CA or Prism 7, GraphPad Software Inc., La Jolla, CA) and significance was 
assigned a p-value of < 0.05. 
 
3. Results  
3.1. Establishment of infectious dose and simulated gastric survival of aEPEC 
Using previously reported qPCR cycle threshold values for amplification of eae from the 
feces of 18 kittens with aEPEC carriage (Watson et al., 2017), we estimated that naturally infected 
kittens shed a range of 3.5 x 103 CFU to 2.0 x 108 CFU (median of 1.8  106 CFU) of aEPEC per 
100 mg feces. Based on these findings, an inoculation dose of 108 CFU per aEPEC isolate was 
chosen for use in experimental infections. A mixture containing all 3 experimental aEPEC isolates 
maintained bacterial quantity over a 2 hour incubation time in the simulated gastric environment 
(average CFU pre-incubation = 3.3  107, post-incubation = 2.95  107). 
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3.2. Pre-existing intestinal infections and aEPEC carriage in vendor-source kittens 
During pre-experimental screening, 4/8 (50%) kittens in Group A were identified with pre-
existing (vendor-origin) aEPEC carriage based on results of fecal culture and in an additional 2 
kittens based on PCR amplification of eae in fecal DNA. In effort to eliminate pre-existing 
aEPEC carriage in Group B kittens, queens and their litters were proactively screened by PCR to 
confirm absence of eae in fecal DNA prior to purchase from the vendor. Despite obtaining kittens 
from only eae-negative queens, 2/8 (25%) Group B kittens were confirmed to be culture positive 
for aEPEC on arrival (Supplementary Table 1).  
Kittens in Group A shared a different pulsotype and serotype of vendor-origin aEPEC 
compared to kittens in Group B. Both of the “vendor-origin” aEPEC isolates differed in pulsotype 
and serotype from the isolates used for experimental infection (Figure 2). Apart from identification 
of subclinical aEPEC carriage, all kittens were considered healthy and no abnormalities were 
observed on clinical examination. The median weight of kittens on arrival was 0.69 kg (range 0.5 
to 0.83 kg). Fecal DNA from each kitten tested negative for feline coronavirus, Tritrichomonas 
foetus, Cryptosporidium spp, feline panleukopenia virus, Clostridium perfringens alpha toxin and 
enterotoxin, Giardia spp, Salmonella spp, Toxoplasma gondii, Campylobacter jejuni, and 
Campylobacter coli. 
 
3.3. Experimentally infected kittens shed live aEPEC 
Following experimental infection, all kittens shed aEPEC, as determined both by direct 
isolation of aEPEC colonies from feces and by qPCR amplification of eae from fecal DNA (Figure 
3). Using the cycle threshold values for eae to estimate CFU of aEPEC, Group A kittens shed 
significantly higher CFU of aEPEC in feces on day 3 post-infection (median, 1.25  107; range, 
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7.64  105 – 6.31  107) compared to Group B kittens (median, 2.74  105; range, 6.64  104 – 2.04 
 106) (P=0.002; Mann-Whitney rank sum test). 
 
3.4. Kittens shed only one pulsotype of aEPEC following experimental infection 
Although three different pulsotypes of aEPEC were administered to each kitten for 
induction of experimental infection, only one of these pulsotypes (isolate 53-1, Figure 2) was 
subsequently shed. Among the 6 kittens in Group A that also harbored a vendor-origin aEPEC 
(K5-1) prior to experimental infection, 2 kittens shed only the vendor-origin aEPEC pulsotype 
after the experimental infection, 2 kittens shed both the vendor-origin pulsotype as well as isolate 
53-1, and 2 kittens shed only isolate 53-1. Despite the carriage of a vendor-origin aEPEC (K15-1) 
by 2 kittens in Group B at the time of purchase, all kittens in this group received antibiotics prior 
to experimental infection after which only the dominant experimental isolate 53-1 was shed. 
 
3.5 Kittens with unaltered intestinal microbiota remain clinically asymptomatic after 
experimental aEPEC infection 
Group A kittens did not receive antibiotics prior to aEPEC infection (Figure 1A). 
Experimental infection of Group A kittens with aEPEC did not result in significant changes in 
food consumption, body weight gain, rectal temperature, or heart rate (Supplementary Figure 1). 
No significant changes in fecal consistency score or percent fecal wet weight were observed in 
Group A kittens following experimental aEPEC infection (Figure 4A).  
 
3.6. Experimental infection of kittens with aEPEC results in significant occult changes in 
intestinal function 
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Despite an absence of changes in fecal consistency score or wet weight, experimental 
aEPEC carriage in Group A kittens was associated with a significant decrease in intestinal 
absorption of D-xylose and a significant decrease in intestinal permeability to iohexol (Figure 5A 
and 5B). Importantly, direct culture of aEPEC with D-xylose (5 mg/ml) for 2 hours in vitro did not 
result in a decrease in D-xylose concentration (post-aEPEC incubation D-xylose, 4.7 and 4.8 
mg/ml) and serum glucose concentration had no significant impact on D-xylose assay results 
(Supplementary Figure 2).  
 
3.7. Kittens pretreated with antibiotics to disrupt the intestinal microbiota prior to aEPEC 
infection become susceptible to diarrhea 
To determine if perturbation of the resident intestinal microbiota increases susceptibility 
of kittens to aEPEC-associated clinical disease, Group B kittens were treated with antibiotics for 
5 days followed by a 2-day washout period prior to experimental infection with aEPEC (Figure 
1B). Fecal aerobic cultures performed during antibiotic administration confirmed an absence of 
any Gram-negative bacteria and diminished numbers of enterococcus bacteria were observed when 
feces were cultured on m-Enterococcus agar. During treatment with antibiotics, significant 
increases in both fecal consistency score and percent wet weight of feces were observed. These 
measurements returned to normal over the 2-day antibiotic washout period prior to introduction of 
experimental aEPEC infection (Figure 4B).  
Similar to Group A kittens, infection of kittens in Group B with aEPEC had no significant 
effect on food consumption, body weight gain, rectal temperature, or heart rate (Supplementary 
Figure 3). However, significant increases were observed in both fecal score and percent wet weight 
of feces after administration of aEPEC (Figure 4B). Group B kittens also had decreases in 
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absorption of D-xylose and permeability to iohexol after administration of aEPEC, however these 
changes were not statistically significant (Figure 5C and 5D). 
 
3.8. Oral administration of a probiotic formulation of feline E. hirae significantly increases 
culture and qPCR detection of E. hirae in feces 
We have previously shown that E. hirae is the dominant member of the mucosa-associated 
enterococci in the small intestine of healthy kittens (Ghosh et al., 2013). To determine the specific 
influence of E. hirae on susceptibility of kittens to aEPEC-associated disease, both groups of 
kittens were randomized to receive either a probiotic formulation of E. hirae or vehicle. Prior to 
administration of the probiotic, each kitten’s feces were determined to be culture negative for E. 
hirae but qPCR positive for the presence of the species-specific murG gene of E. hirae. In Group 
A kittens, probiotic or vehicle were administered orally once a day for 5 days prior to aEPEC 
infection (Figure 1A). Kittens that received the probiotic shed cultivable E. hirae in feces and had 
a significantly greater quantity of murG in feces compared to kittens that received only the vehicle 
(Figure 6). On day 5 of probiotic administration, 3 of the 4 kittens receiving the probiotic were 
fecal culture positive for E. hirae with an average of 4 (range 0 to 5) out of 5 enterococcus isolates 
confirmed as E. hirae. In comparison, none of the kittens receiving the vehicle were fecal culture 
positive for E. hirae. In Group B kittens, probiotic or vehicle were administered orally once a day 
for 9 days beginning immediately after antibiotic-induced disruption of the intestinal microbiota 
and continuing throughout the period of aEPEC carriage (Figure 1B). Results of murG qPCR and 
fecal culture for E. hirae in these kittens was highly variable (Supplementary Figure 4). On day 5 
of probiotic administration, 3 of the 4 kittens receiving the probiotic were fecal culture positive for 
E. hirae with an average of 2 (range 0 to 4) out of 5 enterococcus isolates confirmed as E. hirae. 
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In comparison, 2 of the kittens receiving the vehicle were culture positive for E. hirae with an 
average of 1 (range 0 to 3) out of 5 enterococcus isolates confirmed as E. hirae. No adverse health 
effects such as changes in food intake, body weight, rectal temperature, or heart rate were observed 
to differ between kittens administered E. hirae compared to those that received vehicle. 
 
3.9. E. hirae promotes a decrease in intestinal permeability and ameliorates fecal water loss in 
kittens with aEPEC carriage 
Kittens that were administered E. hirae had either a significantly greater decrease in 
intestinal permeability to iohexol (Group A; Figure 7A) or lower permeability to iohexol at the 
post-infection time-point (Group B; Figure 7B) compared to kittens that received only the vehicle. 
No differences were observed in the absorption of D-xylose after infection with aEPEC between 
kittens receiving E. hirae versus vehicle. In Group B kittens that were pretreated with antibiotics 
to disrupt the intestinal microbiota prior to aEPEC infection, those that received the E. hirae 
probiotic had a non-significantly lower fecal wet weight (mean ± SD = 67 ± 2%) on day 3 post-
infection compared to kittens that received the vehicle (70 ± 3%) (P=0.055; Students’t-test) (Figure 
7C). The effects of E. hirae on intestinal permeability and fecal wet weight were not associated 
with any change in the apparent burden of aEPEC carriage based on estimated CFU in feces 
(Figure 3).  
 
3.10. Experimental aEPEC carriage is eradicated by treatment with pradofloxacin 
On day 8 following aEPEC infection, all kittens were treated orally once a day with the 
fluoroquinolone pradofloxacin (7.5 mg/kg, Bayer, Shawnee Mission, Kansas) for a duration of 7 
days. Pradofloxacin, a fluoroquinolone, was selected based on antimicrobial susceptibility of all 3 
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aEPEC isolates to fluoroquinolones (i.e. enrofloxacin and marbofloxacin)(supplementary Table 
2). On the 7th day of antibiotic treatment, fecal aerobic cultures were negative for presence of 
aEPEC. Likewise, no eae was amplified from the fecal DNA of any kitten at this time point.   
 
4. Discussion 
Results of this study have demonstrated that kittens experimentally-infected with aEPEC 
have sustained shedding of aEPEC and in quantities similar to that observed in naturally infected 
kittens (Watson et al., 2017) and children (Barletta et al., 2011) with diarrhea. A major objective 
of this study was to determine the pathogenicity of aEPEC in kittens. In the absence of an imposed 
disruption of the intestinal microbiota, healthy purpose-bred kittens (Group A) remained clinically 
asymptomatic after experimental aEPEC infection. In contrast, kittens pretreated with antibiotics 
to disrupt the intestinal microbiota (Group B) demonstrated significant increases in fecal scores 
and wet weights consequent to administration of aEPEC. These observations suggest an important 
role of the intestinal microbiota in influencing susceptibility to disease associated with aEPEC 
administration. These findings are similar to those observed in mice infected with the EPEC related 
pathogen, Citrobacter rodentium, where pretreatment with antibiotics increases the severity of 
infection and this is associated with greater numbers of bacteria adhering to the epithelium 
(Wlodarska et al., 2011). We have previously shown that aEPEC adhere to the intestinal epithelium 
of kittens that have died from diarrhea (Ghosh et al., 2013; Nicklas et al., 2010; Watson et al., 
2017). However, we did not examine adherence of aEPEC in the kittens in this study because they 
did not undergo euthanasia. Increases in intestinal water loss by these kittens could reflect a non-
specific effect of E. coli administration, or alternatively the instigation of diarrheal mechanisms 
dependent on bacterial attachment. These mechanisms include inactivation of SGLT-1, inhibition 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 22 
of both NHE3 and the Cl-/HCO3
- exchanger SLC26A3, and internalization of aquaporins, resulting 
in impaired sodium, chloride, and water absorption by intestinal epithelial cells (Dean et al., 2006; 
Gill et al., 2007; Guttman et al., 2007; Hodges et al., 2008).  
In addition to an impact of the intestinal microbiota in determining disease susceptibility, 
it is noteworthy that only one experimental isolate (53-1; O153:H21) established carriage in these 
kittens. Additionally, in a subset of kittens identified as harboring their own “vendor-origin” 
aEPEC, that isolate (K5-1; O88:H-) could outcompete the experimentally-introduced strains. In 
comparing the presence of conserved genes spanning the locus of enterocyte attachment and 
effacement (escN, escV, ler) or previously associated with diarrhea pathogenesis (efa1/lifA) 
(Cepeda-Molero et al., 2017; Slinger et al., 2017), we observed no unique differences between the 
experimental isolates involved in this study. The lack of molecular detection of escN and ler in the 
“vendor-origin” aEPEC may indicate that the T3SS is not functional in these isolates. Further 
genomic and phenotypic analysis of the experimental and vendor-origin isolates could provide 
further insight into virulence attributes (e.g. colicin production, T3SS functionality) capable of 
influencing carriage of some isolates and not others.  
In an effort to gain further mechanistic insight into the pathogenesis of aEPEC carriage in 
kittens, but within the confines of a non-terminal study, we quantified intestinal absorptive and 
barrier function in vivo in kittens before and after experimental infection with aEPEC. These 
studies were conducted by oral administration of D-xylose and iohexol followed by measurement 
of their appearance in serum. The results demonstrated a significant effect of aEPEC 
administration on intestinal absorption and permeability. D-xylose is an exogenous 
monosaccharide whose oral absorption requires transport across the intestinal epithelium 
transcellularly via the sodium-glucose transporter SGLT-1 (Alvarado, 1966) or via passive 
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diffusion (Ohkohchi et al., 1986). The concentration of D-xylose in serum following oral 
administration reflects the absorptive capacity of the intestinal epithelium. Therefore, our 
measurement of lower serum concentrations of D-xylose after, compared to before, aEPEC 
infection supports the onset of significant intestinal malabsorption. While we did not perform a 
histological examination of the intestines of kittens in this study, intestinal malabsorption could 
reflect a non-specific effect of E. coli administration, or alternatively the functional consequence 
of a number of cell-based mechanisms of EPEC pathogenesis including effacement of microvilli 
(Moon et al., 1983), villus blunting due to loss of epithelial cell numbers (Fagundes-Neto et al., 
1997), or a specific inhibitory effect of EPEC effector proteins on SGLT-1 (Dean et al., 2006). It 
is also possible that aEPEC promoted changes in intestinal motility or in the host microbial 
community composition that negatively influenced the absorption of D-xylose. This study also 
demonstrated that kittens experimentally infected with aEPEC had significantly decreased 
intestinal permeability to iohexol. Iohexol is a nonionic, water-soluble, radiocontrast agent whose 
oral absorption requires passive diffusion through paracellar pathways between adjacent intestinal 
epithelial cells (Frias et al., 2012; Gerova et al., 2011). Our observation that intestinal permeability 
to iohexol decreased following aEPEC infection in kittens was somewhat unexpected as cell 
culture studies show that tEPEC increases tight junction permeability by injecting effector proteins 
(e.g. EspF, EspG1/G2, NleA and Map) into host cells in vitro (Glotfelty et al., 2014; McNamara 
et al., 2001; Thanabalasuriar et al., 2010). It is possible that the decrease in intestinal permeability 
observed in vivo in these kittens reflects a non-specific effect of E. coli, or the presence of 
additional influences of aEPEC on epithelial surface area. For example, children with attaching 
and effacing E. coli often have villus blunting which reduces the overall surface area of paracellular 
pathway (Fagundes-Neto et al., 1997; Hyun et al., 1995). Recent studies of infants with 
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environmental enteropathy demonstrate that total epithelial surface area has a greater influence on 
translocation of lipopolysaccharide (LPS) than does the presence of overt epithelial defects and 
tight junction leakage that were documented using confocal laser endomicroscopy (Kelly et al., 
2016).  
A final objective of this study was to explore the potential benefit of a member of the 
healthy intestinal microbiota on intestinal defense against the adverse effects of aEPEC 
administration in these kittens. We have previously established that Enterococcus hirae is the 
predominant mucosa-adherent enterococci species residing in the small intestine of healthy kittens 
(Ghosh et al., 2013; Nicklas et al., 2010). Moreover, in kittens with terminal illness, in which 
aEPEC colonization of the epithelium is prevalent, E. hirae is replaced by increases in mucosal 
colonization with genotypically diverse, virulent, and antimicrobial-resistant E. faecalis (Ghosh et 
al., 2013). This observation is strikingly similar to studies of C. rodentium in interleukin 22 
receptor knockout (IL-22ra1-/-) mice where opportunistic mucosal colonization by virulent E. 
faecalis promotes a greater burden of attachment of C. rodentium to the intestinal epithelium 
(Pham et al., 2014). Results of this study demonstrated that a probiotic formulation of E. hirae was 
highly effective in promoting intestinal colonization and fecal shedding of live E. hirae during 
administration. In kittens with experimental aEPEC carriage, E. hirae appeared to exert its most 
significant influence by promoting a decrease in intestinal permeability. This decrease in 
permeability may indicate an enhancement of the barrier function promoted by E. hirae. While the 
specific mechanism of this observation was not established by this study, others have shown that 
the lipoteichoic acid of E. hirae is able to protect against loss of epithelial tight junction function 
induced by TNF- (Miyauchi et al., 2008). Additionally, E. hirae can limit the secretion of 
inflammatory mediators induced by LPS (Arokiyaraj et al., 2014; Miyauchi et al., 2008) and exerts 
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bactericidal effects against numerous pathogens including E. coli and E. faecalis (Miyauchi et al., 
2008).  
A number of limitations of this study are worthy of discussion. Most importantly, we did 
not include a control group of kittens infected with non-pathogenic E. coli at a similar dose (i.e. 3 
x 108 CFU). Including this control group would have allowed for differentiation between the 
specific influences of aEPEC and possible nonspecific effects of ingesting a relatively high dose 
of similar bacteria. Additional studies will be needed to answer this question. Our study utilized 
a relatively small sample size (n=8) of kittens in each group. These samples sizes were further 
diminished by inclusion within each group of a subset of kittens receiving either an E. hirae 
probiotic or placebo. Despite these conservative numbers, statistically significant differences were 
disclosed for each of the major objectives of the study. Kittens pretreated with antibiotics had 
decreases in intestinal absorption and permeability of D-xylose and iohexol, respectively. 
However, these measurements were not significantly different due to a higher variability in the 
data collected from kittens that had received treatment with antibiotics. Differences in the baseline 
values between the kittens in Group A and Group B made it difficult to assess a comparison of 
severity of intestinal barrier dysfunction between kittens with a “normal” versus disrupted bacterial 
flora prior to aEPEC infection, respectively. Nonetheless, these studies support that a “normal” 
intestinal microbiota may be a strong contributing factor to maintaining an asymptomatic aEPEC 
carriage. To limit the number of animals used, we did not measure intestinal function in an 
uninfected group of kittens to control for any extraneous effect of time (11-12 days) between the 
pre- and post-infection measurements of intestinal absorption or permeability. Despite attempts to 
screen fecal samples from queens and kittens for aEPEC prior to their purchase, a subset of kittens 
in each experimental group was determined to be carrying a “vendor-origin” aEPEC prior to 
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inclusion in this study. No alternate source of kittens designated as specific pathogen free from 
aEPEC existed at the time of this study. The impact of preexisting aEPEC on the results of 
experimental aEPEC infection in these kittens was impossible to ascertain due to the low number 
of kittens falling into each combination of experimental variables. However, mice infected with 
C. rodentium can develop an IgG-dependent acquired immunity and decreased colonization upon 
re-infection (Maaser et al., 2004). Accordingly it is possible that pathogenic effects of aEPEC in 
kittens with prior infection was diminished in this study.   
In summary, results of this study identify aEPEC as a potentially influential pathogen in 
kittens. An ability of aEPEC to promote intestinal malabsorption may explain the association of 
the infection with increased odds of mortality in kittens and children with diarrhea (Kotloff et al., 
2013; Watson et al., 2017). The resident intestinal microbiota have an important impact on disease 
susceptibility, which may in part explain why some kittens and children with the infection remain 
asymptomatic while others are susceptible to diarrhea (Barletta et al., 2011; Watson et al., 2017). 
Fortification of the intestinal microbiota with commensal E. hirae has a potential to ameliorate the 
effect of aEPEC in kittens and is worthy of further study in susceptible populations.  
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Figure Legends  
 
Fig. 1. Timeline (in days) for studies of experimental aEPEC infection in kittens. Panel A 
illustrates the timeline of kittens that did not receive antibiotics prior to aEPEC infection (Group 
A). Panel B illustrates the timeline of kittens that received antibiotics prior to aEPEC infection 
(Group B). Arrows denote specific days on which intestinal function testing was performed. WO 
= wash out period during which antibiotic administration was discontinued prior to aEPEC 
infection.  
 
Fig. 2. Designation, serotype, pulsed-field gel electrophoresis pulsotype, and results of PCR for 
virulence gene content of the three isolates of kitten aEPEC used for experimental infection (5-1, 
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53-1, and 33-2) and two isolates of aEPEC carried by kittens at the time of purchase from a 
commercial vendor (K5-1 and K15-1).  
 
Figure 3. Carriage of aEPEC in kittens following experimental infection. Quantification of aEPEC 
was performed using qPCR to amplify eae from fecal DNA. Results for eae were applied to a 
standard curve relating Ct to CFU of aEPEC to estimate infection load in each kitten at each time 
point (Watson et al., 2017). Panel A data represent kittens in Group A that did not receive treatment 
with antibiotics prior to experimental infection. Note on day 0 of infection, six kittens were 
identified as harboring a vendor-origin aEPEC. Panel B data represent kittens in Group B that 
received pre-treatment with antibiotics prior to experimental infection. Black circles = kittens that 
received probiotic; white circles = kittens that received vehicle only.  
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Figure 4. Pretreatment with antibiotics to disrupt the intestinal microbiota impacts the 
development of clinical signs following experimental aEPEC infection. Panel A data represent 
kittens not treated with antibiotics prior to experimental aEPEC infection. Panel B data represent 
kittens pretreated with antibiotics to disrupt the intestinal microbiota prior to experimental aEPEC 
infection. Graphs represent mean ± standard deviation % fecal wet weight (black circles) and 
median fecal score (gray circles) of kittens over the defined periods of study shown on the x-axis. 
Dashed vertical line indicates the day of infection. Missing data-points reflect times of intestinal 
function assay. For panel B, all values were compared to values on day 5 of acclimation. Fecal 
scores were compared using Wilcoxon Rank Sum and percent wet weight of feces were compared 
using Student’s paired t-test.  *P<0.05, **P<0.01, ***P<0.001. 
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Figure 5. Effect of experimental aEPEC carriage on intestinal absorption of D-xylose and 
permeability to iohexol in kittens following oral administration at time points prior to infection 
(acclimation day 6) and on day 4 post infection. Panel A and B data represent the kittens with 
unaltered intestinal microbiota (group A). Panels C and D data represent the kittens that were 
pretreated with antibiotics to disrupt the intestinal microbiota prior to infection with aEPEC (group 
B). Data points represent individual kittens. Mean value of the data at each time point is 
represented by a horizontal bar. *P<0.05, **P<0.01, Student’s paired t-test. Black circles represent 
kittens that received probiotic and white circles represent kittens that received vehicle only. The 
y-axis scale for iohexol permeability in group B kittens (panel D) reflects a lower baseline 
permeability in this group of kittens compared to kittens in Group A (panel B).  
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Figure 6. Effect of probiotic administration on quantity of E. hirae in feces as determined by qPCR 
assay for presence of the E. hirae specific gene, murG, in fecal DNA. Each data point represents 
an individual kitten’s Ct value compared to the average Ct value of kittens receiving vehicle at the 
same time point. Black circles represent kittens that received probiotic and white circles represent 
kittens that received vehicle (V= vehicle, P=probiotic). Experimental time-course is demonstrated 
along the x-axis. *P<0.05; Mann-Whitney Rank Sum test. 
 
Figure 7. Impact of E. hirae administration on intestinal function and % fecal wet weight of kittens 
experimentally infected with aEPEC. Panel A demonstrates the magnitude of decrease in intestinal 
permeability to iohexol in Group A kittens (undisrupted microbiota) that received vehicle versus 
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E. hirae prior to infection with aEPEC (raw data shown in Figure 5B). Panel B demonstrates 
intestinal permeability to iohexol at the post-infection time-point in Group B kittens (antibiotic-
disrupted microbiota) (raw data shown in Figure 5D). Panel C demonstrates fecal wet weights on 
day 3 of infection in Group B kittens treated with vehicle versus E. hirae. Black circles represent 
kittens that received probiotic and white circles represent kittens that received vehicle only. Bar 
represents the mean; *p<0.05 compared to vehicle treated kittens (Student’s unpaired t-test). 
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